Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP600092.RARunJDRywrJLoEsagqHuQeYNci56JO1UGa6_wI7MPy_A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP600092.RARunJDRywrJLoEsagqHuQeYNci56JO1UGa6_wI7MPy_A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP600092.RARunJDRywrJLoEsagqHuQeYNci56JO1UGa6_wI7MPy_A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP600092.RARunJDRywrJLoEsagqHuQeYNci56JO1UGa6_wI7MPy_A130_provenance.
- NP600092.RARunJDRywrJLoEsagqHuQeYNci56JO1UGa6_wI7MPy_A130_assertion description "[We systematically analyzed the expression of vascular endothelial growth factor A (VEGFA), fibroblast growth factor 2 (FGF2), thrombospondin 1 (THBS1), and brain-specific angiogenesis inhibitor 1 (BAI1), and we correlated the results with microvessel count (MVC), MSI status, p53 mutations, and prostaglandin-endoperoxide synthase 2 (PTGS2) expression in gastric cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600092.RARunJDRywrJLoEsagqHuQeYNci56JO1UGa6_wI7MPy_A130_provenance.
- NP600092.RARunJDRywrJLoEsagqHuQeYNci56JO1UGa6_wI7MPy_A130_assertion evidence source_evidence_literature NP600092.RARunJDRywrJLoEsagqHuQeYNci56JO1UGa6_wI7MPy_A130_provenance.
- NP600092.RARunJDRywrJLoEsagqHuQeYNci56JO1UGa6_wI7MPy_A130_assertion SIO_000772 17374440 NP600092.RARunJDRywrJLoEsagqHuQeYNci56JO1UGa6_wI7MPy_A130_provenance.
- NP600092.RARunJDRywrJLoEsagqHuQeYNci56JO1UGa6_wI7MPy_A130_assertion wasDerivedFrom befree-2016 NP600092.RARunJDRywrJLoEsagqHuQeYNci56JO1UGa6_wI7MPy_A130_provenance.
- NP600092.RARunJDRywrJLoEsagqHuQeYNci56JO1UGa6_wI7MPy_A130_assertion wasGeneratedBy ECO_0000203 NP600092.RARunJDRywrJLoEsagqHuQeYNci56JO1UGa6_wI7MPy_A130_provenance.
- befree-2016 importedOn "2016-02-19" NP600092.RARunJDRywrJLoEsagqHuQeYNci56JO1UGa6_wI7MPy_A130_provenance.